<unk>  is a factor Xa inhibitor that is FDA approved for the prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include urinary tract infection, constipation, and hypokalemia.
Betrixaban
Enoxaparin
Apixaban
Dabigatran
Iotalamic acid
Oxeladin
Edoxaban
Darexaban